First denied, FL brain tumor patient says $1M surgery bill is covered Your Money, Their Medicine Why some Tampa Bay families are dropping health insurance for cash care Tampa doctors offer patients membership medicine Florida freestanding ER bills stun patients after…
A modified algorithm using a high-sensitivity cardiac troponin T (hs-cTnT) assay safely and rapidly ruled out more patients with myocardial infarction in one US emergency department, with more than half of patients ruled out 1 hour after presentation, when compared with…
Home » ICMR-NIHR Bhubaneswar to Host Regional ADOPT Sensitisation Meeting on Health Technology Assessment The ICMR–National Institute of Health Research (ICMR-NIHR), Bhubaneswar, will host the Regional ADOPT Sensitisation Meeting on Health Technology Assessment (HTA) for Eastern India on Oct 30, 2026, at…
Updated - October 29, 2026 01:22 pm IST The story so far: The Indian Patent Office has rejected a patent application filed by the U.S.-based Global Alliance for TB Drug Development (TB Alliance) for the combination of bedaquiline, pretomanid and linezolid, known as BPaL.
Aizawl, Oct 29 (PTI) Respiratory diseases accounted for the largest proportion of medically certified deaths in Mizoram in 2025, followed by digestive ailments, according to a report released by the northeastern state’s chief registrar of births and deaths. The Medical Certification of…
Dermatology Times connects dermatology professionals with key skin disorder coverage, therapeutic strategies, clinical trial updates, and expert insights. The US Food and Drug Administration (FDA) has approved an update to the prescribing information for risankizumab-rzaa (SKYRIZI; AbbVie), revising recommendations surrounding…
Mumbai, October 27, 2026: In a significant step towards making treatment more affordable for patients with drug-resistant tuberculosis (MDR-TB), the Indian Patent Office has rejected a patent application filed by the Global Alliance for TB Drug Development (TB Alliance). The office upheld…
Updated - October 28, 2026 06:53 pm IST - New Delhi The Indian Patent Office has rejected a patent application filed by the U.S.-based Global Alliance for TB Drug Development (TB Alliance) for the combination of bedaquiline, pretomanid, and linezolid (BPaL), a six-month, all-oral treatment…
Artificial intelligence (AI) can offer significant benefits but also pose risks if used without caution, experts said at the Times Network India Health Summit 2026, emphasizing the need for responsible and judicious use of the technology. The experts acknowledged the growing…
Nearly 1 in 3 patients with inflammatory bowel disease receive biologic agents or JAK inhibitors within 5 years of diagnosis, and their use is linked to a lower risk for hospitalisations. Use of Biologics or JAK Inhibitors Tied to Lower Risk for Hospitalisations…
Tuberculosis: cases, drug-resistant TB, screening, new treatments and elimination programmes such as India's TB Mukt Bharat.
An article joins this feed when it matches these terms. Each one is also a search of its own.